Price$0.28-0.44 (-61.58%)
2026-03-042026-06-05
News · 26 weeks22-50%
2025-12-142026-06-07
Mix1490d
- SEC Filings7(50%)
- Other6(43%)
- Earnings1(7%)
Latest news
25 items- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingTORONTO and GLIL YAM, Israel, June 3, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender"). Pursuant to a note purchase agreement between the Company and Lender dated June 3, 2026 (the "June Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the "June Note").The June Note bears interest at a rate of 8% per annum, increasing to 14% upon the occurrence and continuation of
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Corp. Announces First Quarter 2026 Financial ResultsTORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced its financial results for the first quarter ended March 31, 2026. All amounts were reported in Canadian dollars, unless otherwise stated. For the three months ended March 31, 2026, the Company recorded revenues of $8.7 million, gross profit of $1.4 million, operating loss of $1.7 million, and a net loss of $2.5 million, or $0.38 per share. The Company also continued to advance its co
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note FinancingsTORONTO and GLIL YAM, Israel, May 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$300,000 convertible note financing in a private placement with an institutional investor, bringing the total gross proceeds raised in recent similar financings to US$550,000. First NotePursuant to a note purchase agreement between the Company and Lender dated April 6, 2026 (the "First Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$250,000, with an original issuance discount of 10% (the "First Note").The First Note bears interest at
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIMC Announces Receipt of Nasdaq Minimum Bid Price NotificationTORONTO and GLIL YAM, Israel, April 10, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has received a written notice (the "Notice") from Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a period of 180 calendar days to regain compliance with the minimum bid price requirement. The N
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash FlowTORONTO and GLIL YAM, Israel, March 31, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today reported its audited consolidated financial results as of and for the full year ended December 31, 2025. The Company achieved a major operational milestone by generating positive cash flow from operating activities of C$4.7 million for the year ended December 31, 2025, a significant turnaround from negative cash flow in 2024, while delivering high revenue growth in Germany, completing financing transactions, and strengthening its cash position. 2025 Key Highlights (All figures in CAD thousands):Revenue t
- SECSEC Form 20-F filed by IM Cannabis Corp.20-F - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe TechnologiesTORONTO and GLIL YAM, Israel, March 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced that, following its previous announcement regarding its decision to explore the introduction of additional business activities, it has entered into a non-binding letter of intent (the "LOI") to acquire 51% of Blackaxe Technologies Spolka z Organiczona ("Blackaxe"), a Polish technology company specializing in advanced defense and intelligence solutions. The proposed transaction represents a potential strategic expansion for IMC into the defense and homeland security technology sectors.Black Axe
- SECSEC Form EFFECT filed by IM Cannabis Corp.EFFECT - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form F-3 filed by IM Cannabis Corp.F-3 - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raises US$2,171,660.40 in Note Purchase AgreementsTORONTO and GLIL YAM, Israel, Jan. 26, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced that it has raised a total of US$2,171,660.40 in debt financings from an arm's length third party (the "Lender") in order to manage the Company's current liquidity requirements. First Note Pursuant to a note purchase agreement between the Company and Lender dated January 7, 2026 (the "First Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$1,538,749, after application of an original issuance discount of 10% (the "First Note"). The First Note b
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of DirectorsTORONTO and GLIL YAM, Israel, Jan. 5, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), medical cannabis company with operations in Israel and Germany, announced today that Mr. Alon Dayan has been appointed to the Company's board of directors effective December 31, 2025. Mr. Dayan, who is currently the Chief Executive Officer of KeepZone AI Inc., a position he has held since 2025, brings over 15 years of executive experience in the homeland security technology sector, with a proven track record of founding and scaling innovative companies focused on systems integration, secure communications, and international business development. As the founder and Chief Execu
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol ResearchEngages Exclusive Financial Advisors for U.S. Opportunities and Potential Divestitures of German and Israeli Operations TORONTO and GLIL YAM, Israel, Dec. 30, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), medical cannabis company with operations in Israel and Germany, today announced that it is actively evaluating certain strategic opportunities to expand its operations into the United States cannabis market. This initiative follows President Donald Trump's executive order signed on December 18, 2025, which directs the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act, recognizing it
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Appoints Asi Levi as Chief Financial OfficerTORONTO and GLIL YAM, Israel, Dec. 12, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced, further to its press release dated October 29, 2025, the appointment of Asi Levi, CPA, as the Company's Chief Financial Officer ("CFO"), effective immediately, to replace Uri Birenberg. Mr. Levi has over 15 years of experience in finance and controlling roles, including serving as Chief Financial Officer of Water Ways Technologies Inc. and DekelOil CI, part of Dekel Agri-Vision Plc and as Controller of SciSparc Ltd. and A2Z Cust2Mate Solutions Corp. He has overseen fundraising efforts
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
IMCC FAQ
6 questionsWhat does IM Cannabis Corp. do?
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.Where does IMCC stock trade?
IM Cannabis Corp. (IMCC) is listed on NASDAQ.What sector and industry is IMCC in?
IM Cannabis Corp. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about IMCC?
IM Cannabis Corp. has had 3 recent analyst actions on file. The most recent action was from ROTH Capital: Buy with a $800.00 price target on 2021-10-05. Recent price targets range from $800.00 to $1050.00.What companies are similar to IMCC?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), RLX (RLX Technology Inc.). Compare IMCC side-by-side with any of them on Quantisnow.How can I track IMCC on Quantisnow?
Quantisnow aggregates IM Cannabis Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IMCC to receive live email and push alerts on every new disclosure.